Blue Star Capital plc (AIM:BLU)
London · Delayed Price · Currency is GBP · Price in GBX 8.50
0.00 (0.00%)
At close: Mar 24, 2026
Blue Star Capital Revenue
In the fiscal year ending September 30, 2025, Blue Star Capital had annual revenue of -346.93K GBP. Blue Star Capital had revenue of -345.91K in the half year ending September 30, 2025.
Revenue
-346.93K
Revenue Growth
n/a
P/S Ratio
-11.65
Revenue / Employee
-115.64K
Employees
3
Market Cap
4.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | -346.93K | 3.98M | - |
| Sep 30, 2024 | -4.33M | 1.56M | - |
| Sep 30, 2023 | -5.89M | -5.10M | - |
| Sep 30, 2022 | -784.06K | -3.24M | - |
| Sep 30, 2021 | 2.46M | 402.71K | 19.58% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vox Valor Capital | 10.06M |
| Sure Ventures | 3.30M |
| Seed Innovations | 1.62M |
| Tiger Alpha | 232.99K |
| Mindflair | 4.00K |
| Primorus Investments | -95.00K |
| Frontier IP Group | -2.72M |
| British & American Investment Trust | -5.45M |
Blue Star Capital News
- 7 weeks ago - AIM Market Roundup: Physiomics, Harvest Minerals, Blue Star Capital - The Armchair Trader
- 9 months ago - AIM Market Roundup: Tungsten West, Blue Star Capital, Ariana Resources - The Armchair Trader
- 9 months ago - AIM Market Roundup: Autins, Haydale Graphene, Gear4music - The Armchair Trader
- 10 months ago - AIM Market Roundup: Sundae Bar, GCM Resources, Mirriad Ads - The Armchair Trader
- 10 months ago - AIM Market Roundup: Celadon Pharma, Blue Star Capital, Synergia - The Armchair Trader
- 10 months ago - AIM Market Roundup: Blue Star Capital, Pri0r1ty Intelligence, Smarttech 247 - The Armchair Trader
- 1 year ago - AIM Market Roundup: Inspiration Healthcare up 84% - The Armchair Trader
- 1 year ago - AIM Market Roundup: Blue Star Capital, Enteq, Fiinu - The Armchair Trader